Patents Assigned to Proteus Digital Health, Inc.
  • Patent number: 11044024
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: June 22, 2021
    Assignee: Proteus Digital Health, Inc.
    Inventors: Mark Zdeblick, Timothy Robertson, Aleksandr Pikelny, Hooman Hafezi
  • Patent number: 10720044
    Abstract: A headwear device for detecting an electrical signal generated by an ingestible event marker is disclosed. The headwear device includes a detection subsystem to receive an electrical signal generated by an ingestible event marker from a detection arrangement. A processing subsystem is coupled to the detection subsystem to decode the electrical signal. A radio subsystem is configured to transmit the decoded electrical signal to a wireless node. A system includes the headwear device and the detection arrangement. A method includes receiving the electrical signal generated by the ingestible event marker at the headwear device, decoding the electrical signal to extract information associated with the ingestible event marker, and transmitting the information to a wireless node.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: July 21, 2020
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Mark Zdeblick, Arna Ionescu Stoll, William McAllister, Kit Yee Au-Yeung
  • Patent number: 10682071
    Abstract: The disclosed system includes an ingestible event marker device configured to collect Ingestible Event Marker (IEM) data from a body of an individual and transmit a signal including the IEM data, wherein the IEM data include information associated with an ingestion event, a receiver adapted to be associated with the body of the individual and configured to receive the signal including the IEM data via the body of the individual, a hub to receive the IEM data from the receiver, and at least one IEM data system to receive the IEM data from the hub. The at least one IEM data system analyzes the IEM data and generates at least one metric based on the IEM data. The at least one IEM data system may further generate predictive information based on the at least one metric, wherein the predictive information is related to prediction of a state of the individual.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: June 16, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventor: Yashar Behzadi
  • Patent number: 10653875
    Abstract: A pharmaceutical product including a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid, an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing, and a protective material that encompasses the ingestible device. The ingestible device may be attached to a flexible component, wherein the flexible component is configured to releasably secure the ingestible device within the housing.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 19, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Raymond Schmidt
  • Patent number: 10610128
    Abstract: A system for administering prescription medications including a composition and a receiver. The composition may include an active agent, an identifier, and a pharmaceutically acceptable carrier. The active agent may include a controlled pharmaceutical. The identifier may include: a partial power source having a first material and a second material configured to generate a voltage in contact with a conductive fluid within a body of a patient, and a signal generation component configured to use at least a portion of the generated voltage to transmit a signal through the body of the patient. The receiver may be positioned near the body of the patient, wherein the receiver is configured to: receive the signal transmitted through the body of the patient, and automatically report the signal for at least one of identification of the controlled pharmaceutical or tracking physical administration of the controlled pharmaceutical to the body of the patient.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: April 7, 2020
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Mark Zdeblick, Andrew Thompson, Aleksandr Pikelny, Timothy L. Robertson, Hooman Hafezi
  • Patent number: 10588544
    Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.
    Type: Grant
    Filed: February 23, 2016
    Date of Patent: March 17, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Kit Yee Au-Yeung, Robert Duck, Maria Holen, Timothy Robertson, Benedict Costello
  • Patent number: 10542909
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: January 28, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Mark Zdeblick, Timothy Robertson, Aleksandr Pikelny, Hooman Hafezi
  • Patent number: 10529044
    Abstract: A system and method are disclosed that track a deliverable to a user. The system includes an identifier or tag secured to the deliverable, a computer system for interrogating the identifier, and a personal device in communication with the computer system, wherein the personal device is held by the user at the time the user is administered the deliverable to detect the unique identity associated with the identifier device and confirms delivery of the deliverable to the user. The method includes attaching an identifiable tag that produces a unique signature to the deliverable, interrogating the tag at about the time of delivery to the user, and confirming that the user has been administered the deliverable through detecting the identifiable tag.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: January 7, 2020
    Assignee: Proteus Digital Health, Inc.
    Inventors: Todd Thompson, Lawrence Arne, Fataneh Omidvar, Yashar Behzadi, Robert Duck, Lorenzo Dicarlo, Gregory Moon
  • Patent number: 10517507
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can also measure the conditions of the environment surrounding the system.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: December 31, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventors: Jeremy Frank, Peter Bjeletich, Hooman Hafezi, Robert Azevedo, Robert Duck, Iliya Pesic, Benedict Costello, Eric Snyder
  • Patent number: 10517506
    Abstract: Low profile antennas for ingestible devices, such as ingestible event markers, are provided. Aspects of the ingestible devices of the invention include low profile signal transmission antennas configured such that they are flexible or degrade after use, allowing the antenna and attached components to pass easily through the body. Embodiments of the low profile antennas are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: December 31, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventors: Timothy L. Robertson, Olivier Colliou, Eric J. Snyder, Mark Zdeblick
  • Patent number: 10498572
    Abstract: A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: December 3, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Robert Fleming, Cherie Kushner, William H. McAllister, Mark Zdeblick
  • Patent number: 10421658
    Abstract: The apparatus and methods of the current invention utilize a container having an interlock that prevents filling the container, dispensing from the container, or both, as well as a detecting mechanism that senses a unique identifier associated with a particular product allowing its use in conjunction with the container.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: September 24, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventor: Andrew Thompson
  • Patent number: 10376218
    Abstract: A device for gathering data has first and second electrodes. The first electrode is coupled to a surface of interest, and the second electrode is coupled to “everything else” or “the air”. The first electrode is shielded from the second, and from most sources of parasitic capacitance, by a shield that is driven by an active driver that drives the shield to track, and ideally to match, the instantaneous potential of the electrode. The second electrode is likewise shielded in a similar way from most sources of parasitic capacitance. These shields likewise help to limit the extent to which RFI from the device electronics couples with either of the electrodes. In this way the sensing device achieves a markedly better signal-to-noise ratio at frequency bands of interest.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: August 13, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Mark Zdeblick, James Hutchison, Lawrence Arne
  • Patent number: 10305544
    Abstract: A system for tracking a product from origin to destination is disclosed. The system includes a probe that comprises two plates, a power source and a processor. The power source is controlled by the processor to produce an oscillating output at the plates. Using the oscillating voltage, the probe interrogates a device through capacitive coupling. The device includes a control unit, a memory unit, and first and second materials physically associated with the device for communication using capacitive coupling. Information associated with the device is transferred from the device to the probe through capacitive coupling between the first and second materials and the first and second plates, respectively.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: May 28, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventor: Mark J. Zdeblick
  • Patent number: 10238604
    Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: March 26, 2019
    Assignee: Proteus Digital Health, Inc.
    Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
  • Patent number: 10223905
    Abstract: A mobile device for detecting an electrical signal generated by an ingestible event marker is disclosed. The mobile device includes a detection subsystem to receive an electrical signal generated by an ingestible event marker from a detection arrangement. A processing subsystem is coupled to the detection subsystem to decode the electrical signal. A radio subsystem is configured to transmit the decoded electrical signal to a wireless node. A system includes the mobile device and the detection arrangement. A method includes receiving the electrical signal generated by the ingestible event marker at the mobile device, decoding the electrical signal to extract information associated with the ingestible event marker, and transmitting the information to a wireless node.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: March 5, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Mark Zdeblick, Arna Ionescu Stoll, William McAllister, Kit Yee Au-Yeung
  • Patent number: 10207093
    Abstract: The present invention discloses multiple approaches to preventing the capsule walls and other material from interfering with the performance of an electronic device once the device is activated by surrounding fluid. In accordance with the teachings of the present invention, a miniature ingestible device (MID) may be created using excipients and films. The MID, in accordance with various aspects of the present invention, will have a coating or laminating surrounding an electronic device and separating and isolating the device from the pharmaceutical product or drug within the capsule once the capsule is ingested as well as from the capsule itself as the capsule walls begin to collapse during the disintegration process.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: February 19, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Timothy Robertson, Hooman Hafezi, Raymond Schmidt
  • Patent number: 10187121
    Abstract: Provided is an electronic device having a control device, a driver circuit coupled to the control device. The driver circuit is configured to alter conductance. A partial power source is coupled to the control device and is configured to provide a voltage potential difference to the control device and the driver circuit as a result of the partial power source being in contact with a conductive fluid. The partial power source includes a first material electrically coupled to the control device and a second material electrically coupled to the control device and electrically isolated from the first material. An inductor is coupled to the driver circuit. The driver circuit is configured to develop a current through the inductor. The magnitude of the current developed through the inductor is varied to produce an encoded signal that is remotely detectable by a receiver. Receivers to receive and decode also are disclosed.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: January 22, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Alireza Shirvani, Mark Zdeblick, Jonathan Withrington
  • Patent number: 10175376
    Abstract: Provided is an apparatus, system, and method for detecting a metal contaminant in a sensor-enabled dose form. According to the method, a sensor-enabled dose form is oriented in a predetermined orientation. The sensor-enabled dose form is received through an aperture of a metal detector. A detection signal is generated by the metal detector in response to receiving the sensor-enabled dose form through the aperture of the metal detector. The detection signal is compared to a predetermined threshold. The presence of a metal contaminant in the sensor-enabled dose form is determined based on the comparison of the detection signal and the predetermined threshold. In another method, the sensor-enabled dose form is first oriented in a first orientation and then in a second orientation. The apparatus includes a guide, a metal detector, and a comparator circuit. The system further includes a controller to reject contaminated sensor-enabled dose forms.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: January 8, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Raymond Schmidt, Patricia Johnson, Maria Holen, Richard Huang, Alvin Thai
  • Patent number: 10097388
    Abstract: A method may include receiving a signal. The signal may encode a data packet. The method may include further sampling the signal to generate sampled values, and generating a slice record comprising a plurality of slices from the sampled values by correlating the sampled values with first and second reference templates. The first reference template may include a first reference function, and the second reference template may include a second reference function in quadrature with the first reference function. The method may further include cross-correlating the slice record with a stored template to generate cross-correlation terms, and determining when a magnitude of the cross-correlation terms exceeds a predetermined threshold for a width of the stored template.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: October 9, 2018
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Robert Fleming, Cherie Kushner, William H. McAllister, Mark Zdeblick